Series B funding round for Scribe Therapeutics raising $100M in March 2021
Series B funding round for Scribe Therapeutics raising $100M in March 2021
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Krishna Yeshwant |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$120M
Top Valuation
-
Scribe Therapeutics raised $100M in a Series B round.
The round was announced on 03/01/21.